If PAB can actually pull off a deadline and get some runs on the board that should be enough fuel to get see some strong SP growth on the back of biotech recovery in general. The market hates delays and as is common with biotech punishes accordingly factoring in cash position too. IMO it’s a bit of a gamble at the moment. A lot is hinging on this GMP because if it’s another delay or ‘sporadic event’ than the good Drs words seemingly aren’t even worth the paper they’re written on imho. Watching this one closely.
If PAB can actually pull off a deadline and get some runs on the...
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $16.46M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $528 | 66.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 4671418 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 960403 | 8 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.7¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.7¢ | 0.7¢ | 0.7¢ | 156250 | ||
| Last updated 10.36am 14/06/2024 ? | |||||
| PAB (ASX) Chart |